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ABSTRACT 
Evidence for shear stress as a regulator of carotid artery dilation in response to increased arterial 
carbon dioxide was recently demonstrated in humans during sustained elevations in CO2 
(hypercapnia); however, the relative contributions of CO2 and shear stress to this response remains 
unclear. We examined the hypothesis that, following a 30-second transient increase in arterial CO2 
tension and consequent increase in internal carotid artery shear stress, internal carotid artery 
diameter would increase, indicating shear-mediated dilation, in the absence of concurrent 
hypercapnia. In 27 healthy participants the partial pressures of end-tidal O2 and CO2, ventilation 
(pneumotachography), blood pressure (finger-photoplethysmography), heart-rate 
(electrocardiogram), internal carotid artery flow, diameter and shear stress (high resolution duplex 
ultrasound) and middle cerebral artery blood velocity (transcranial Doppler) were measured during 
4-minute steady state and transient 30-second hypercapnic tests (both +9mmHg CO2). Internal 
carotid artery dilation was lower in the transient, compared to the steady state hypercapnia 
(3.3±1.9% vs. 5.3±2.9%, respectively; P<0.03). Increases in internal carotid artery shear stress 
preceded increases in diameter in both the transient (time: 16.8±13.2s vs. 59.4±60.3s; P<0.01) and 
steady state (time: 18.2±14.2s vs. 110.3±79.6s; P<0.01) tests. Internal carotid artery dilation was 
positively correlated with shear rate area under the curve in the transient (r2=0.44; P<0.01), but not 
steady state (r2=0.02; P=0.53) trial. Collectively, these results suggest that hypercapnia induces 
shear-mediated dilation of the internal carotid artery in humans. This study further promotes the 
application and development of hypercapnia as a clinical strategy for the assessment of 
cerebrovascular vasodilatory function and health in humans. 
Key Words: Cerebral blood flow; carbon dioxide; shear stress; flow-mediated dilation; 
transcranial Doppler; Ultrasound 
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NEW AND NOTEWORTHY 
 
Shear stress dilates the internal carotid artery in humans. This vasodilatory response occurs 
independent of other physiological factors as demonstrated by our transient CO2 test, and is 
strongly correlated to shear AUC. Assessing carotid shear-mediated dilation may provide a future 
avenue for assessing cerebrovascular health and risk of cerebrovascular events. 
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INTRODUCTION 
The endothelium is integral to the maintenance of vascular health and function in humans. 
Endothelial dysfunction is an early and integral event in the pathogenesis of atherosclerosis as well 
as cardio- and cerebro-vascular diseases (20).  In the peripheral and coronary vasculature, flow 
mediated dilation (FMD) has been used as a functional bioassay to assess endothelial health. The 
FMD test strongly predicts cardiac events(18), potentially allowing for pre-clinical detection of 
future cardiovascular disease(12). While the conventional FMD test is based on the notion that a 
healthy endothelium produces autocoids (e.g. nitric oxide) that induce a quantifiable dilator 
response to an imposed increase in shear stress(17), there is currently no equivalent assessment of 
cerebrovascular function in humans. Although standard carbon dioxide (CO2) reactivity tests using 
transcranial Doppler are predictive of cerebrovascular events (i.e. stroke) in individuals with pre-
existing carotid stenosis(19), its use is limited as it does not provide significant predictive value 
pertaining to stroke risk in apparently healthy individuals(30). Other metrics of cerebrovascular 
function such as neurovascular coupling(27) and cerebral autoregulation(39, 44) are similarly 
impaired in clinical populations, but are not predictive of risk in apparently healthy individuals. 
Therefore, the development of an FMD-type test that could potentially provide an index of 
cerebrovascular endothelial function may prove to be clinically impactful. 
 
Recently, our group has provided the first evidence in humans of shear-mediated dilation in the 
internal carotid artery (ICA)(10). Here, we demonstrated that vascular responsiveness to CO2 was 
related to the rise in intra-arterial shear stress, leading to vasodilation with a similar time 
dependency to that of peripheral FMD. However, the carotid vasodilation observed in that study 
coincided with elevated arterial PCO2 levels and we could not partition the effects of shear stress 
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from those occurring secondary to sustained hypercapnia [e.g. elevated blood pressure(33), cardiac 
output(7), chemoreceptor-mediated sympathoactivation(28), potential direct vasomotor effects of 
CO2(21, 23, 47)].  As a result, the contribution of shear-dependent mechanisms to human CBF 
regulation and carotid dilator function requires further investigation in vivo.  
 
Therefore, the primary purpose of this experiment was to extend our previous findings(10), using 
a test without sustained hypercapnia, to quantify the role that shear stress-dependent mechanisms 
play in carotid dilation in response to CO2 reactivity. It was hypothesized that transient (30-second) 
increases in end-tidal PCO2 (PETCO2) would produce an ICA shear response similar to that of a 
peripheral FMD test (i.e. bell-curve). We further reasoned that upon return of PETCO2 to baseline 
values, and consequent withdrawal of the direct effects of CO2, a time dependent dilation of the 
ICA would occur (e.g. 30-60 second delay from shear onset), implying a shear-specific mechanism 
that is consistent with that observed in peripheral vessels of young healthy individuals(9).  
 
MATERIALS AND METHODS 
Ethical Approval 
This study was approved by the University of British Columbia Clinical Research Ethics Board 
and the University of Western Australia Human Research Ethics Committee, and data was 
subsequently collected at both institutions. Prior to participation in the study, all participants 
completed written informed consent. All procedures conformed to the standards set by the 
Declaration of Helsinki. 
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Research Participants 
Twenty-seven healthy (twenty two male, five female), young volunteers (mean±SD; 22±3 years; 
body mass index=22±2 kg/m2) were recruited to participate in this study. Following written 
informed consent and familiarization the participants attended the laboratory on one occasion 
having fasted for ≥2 hours and refrained from exercise, alcohol and caffeine for 24 hours. During 
familiarization, participants were screened to ensure that reliable ICA ultrasound images and 
middle cerebral artery (MCA) signals could be obtained. Participants were familiarized with the 
remaining experimental equipment and procedures during this session. All participants were free 
of cardiovascular, respiratory, and cerebrovascular disease, were non-diabetic, and were not taking 
any prescription drugs (other than oral contraceptives; n=4) at their time of participation, as 
determined by a screening questionnaire. All females were tested in days 1-3 of their follicular 
phase. Of the 27 participants recruited, 24 completed both CO2 protocols, while three only 
completed the transient CO2 protocol. 
 
Experimental Measures 
Cardiorespiratory Measures.  
All cardiorespiratory variables were sampled continuously at 1KHz via an analogue-to-digital 
converter (Powerlab, 16/30; ADInstruments, Colorado Springs, CO). Heart rate (HR) was 
measured by 3-lead electrocardiogram (ADI bioamp ML132), while beat-to-beat blood pressure 
was measured by finger photoplethysmography (Finometer PRO, Finapres Medical Systems, 
Amsterdam, Netherlands). The Finometer reconstructed brachial waveform was used for the 
calculation of mean arterial pressure (MAP) after values were back calibrated to the average of 
three automated brachial blood pressure measurements made over 5-minutes at rest (Tango+; 
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SunTech, Morrisville, NC). Both PETCO2 and the end-tidal partial pressure of O2 (PETO2) were 
sampled at the mouth and recorded by a calibrated gas analyzer (model ML206, ADInstruments), 
while respiratory flow was measured by a pneumotachograph (model HR 800L, HansRudolph, 
Shawnee, KS) connected in series to a bacteriological filter. All data were interfaced with LabChart 
(Version 7). 
 
Dynamic End-Tidal Forcing.  
The PETO2 and PETCO2 were controlled by a portable dynamic end-tidal forcing system that has 
been previously described in detail(42, 43). Our end-tidal forcing system effectively controls end-
tidal gases through wide ranges of PETCO2 and PETO2 independent of ventilation(42, 43) and has 
been previously used for similar P ETCO2 manipulations(21). 
 
Cerebrovascular Measures.  
Blood velocity in the right MCA (MCAv) was measured using a 2MHz transcranial Doppler 
ultrasound (TCD; Spencer Technologies, Seattle, WA). The TCD probe was fixed to a headpiece 
(model M600 bilateral head frame, Spencer Technologies) and secured into place. The MCA was 
insonated through the middle trans-temporal window, using previously described location and 
standardization techniques(46).  
 
Internal Carotid Artery Measurements 
Right ICA blood velocity (ICAv) and vessel diameter were measured using a 10MHz multi-
frequency linear array duplex ultrasound (Terason T3200, Teratech, Burlington, MA). 
Specifically, B-mode imaging was used to measure arterial diameter, while pulse-wave mode was 
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used to concurrently measure peak blood velocity. Diameter and velocity of the ICA were 
measured at least 1.5 cm distal to the common carotid bifurcation to eliminate recordings of 
turbulent and retrograde flow and non-uniform shear. Great care was taken to ensure that the 
insonation angle (60°) was unchanged throughout each test. Further, upon acquisition of the first 
ultrasound image (i.e., resting baseline) there was no alteration of B-mode gain to avoid any 
artificial changes in arterial wall brightness/thickness. All recordings were made in accordance 
with published guidelines(41). 
 
All recordings were screen captured and stored as video files for offline analysis. This analysis 
involved concurrent determination of arterial diameter and peak blood velocity at 30Hz, using 
customized edge detection and wall tracking software (BloodFlow Analysis, Version 5.1) designed 
to mitigate observer bias(49). Our within day coefficient of variation for the assessment of ICA 
diameter is 1.5% using this technique(21). Blood flow and shear rate were subsequently calculated 
as previously described(9, 21).  
 
Experimental Protocol 
Carotid Shear-Mediated Dilation Tests 
Prior to commencing the study, pilot testing was ran to determine the optimal PETCO2 change 
required to elicit a maximal transient shear stress response. Although it is well established that the 
cerebral blood flow response is linear with elevations in PETCO2 (1),  we determined that there was 
no appreciable difference in the transient test shear response between a targeted PETCO2 stimuli of 
+9 or +15mmHg. Given that +15 leads to a greater extent of participant discomfort, and a larger 
ventilatory response, which would increase the difficulty of acquiring ultrasound recordings of the 
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ICA, we reasoned that a +9mmHg stimulus would be better suited to address our research question. 
In addition, the +9mmHg stimulus is roughly comparable to what would be induced by an FICO2 
of 0.05 – this level is commonly used in other studies (1). 
 
Two separate CO2 tests were utilized to assess the influence of shear and flow on ICA vascular 
tone: 1) a transient CO2 test (+9 mmHg PETCO2) to simulate the shear dynamics characteristic of 
a post occlusion brachial cuff release in standardized peripheral FMD tests(40) (Figures 1 & 2), 
and 2) a steady state CO2 test to determine maximal reactivity/dilation to the same +9mmHg 
stimulus. The steady state CO2 test was conducted fifteen minutes following the transient test. 
1) Transient CO2 Test: Participants lay supine, while breathing room air. Following five 
minutes of resting data collection, participants breathed simulated room air delivered from 
the end-tidal forcing system (i.e. PETO2 & PETCO2 did not change) for two minutes. 
Participants were then paced at 20 breaths per minute through verbal coaching and visual 
feedback while end-tidal values were maintained (i.e. did not change) for an additional two 
minutes. Breathing was maintained at 20 breaths per minute for the remainder of the trial. 
This approach was utilized to improve the end-tidal forcing systems ability to abruptly 
manipulate PETCO2 in a controlled fashion, as a higher breathing rate allows for quicker 
gas manipulations. Further, this eliminated the potential for abrupt changes in VE due to 
CO2 chemosensitivity, which could interfere with ultrasound imaging (e.g., large neck 
muscle movements) and act as a confounding physiological factor.  At the two minute 
mark, PETCO2 was abruptly (~five seconds) elevated to +9 mmHg above baseline for 30-
seconds and then quickly returned to baseline values, which were maintained for three 
additional minutes. Reported data are from the last minute of hyperventilation onwards. 
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2) Steady State CO2 Test: Participants lay supine, while breathing room air. Following five 
minutes of resting data collection, the participant breathed simulated room air on the end-
tidal forcing system. Following two minutes of steady breathing, PETCO2 was abruptly 
(~five seconds) elevated to +9 mmHg above baseline and maintained for four minutes. 
Following four minutes, participants returned to room air breathing.  
 
Data Analysis 
Data Extraction and Carotid Shear-Mediated Dilation Software 
All data from LabChart (e.g. MCAv, MAP, PETCO2 and PETO2) were down sampled to 50Hz and 
exported into Microsoft Excel. Vascular data were interpolated at 50Hz and exported into the same 
excel spreadsheet and time-aligned with the LabChart data. The excel spreadsheet was re-opened 
as a LabChart data file and all cardiovascular/cerebrovascular data were exported to a new excel 
spreadsheet in beat-by-beat averages, while all respiratory variables were exported on a breath-by-
breath basis. These variables were subsequently analyzed using custom designed shear-mediated 
dilation software (Labview®) as previously explained in detail(10). In brief, the data were filtered 
and the following variables were automatically detected and calculated: 1) Baseline values; 2) 
Peak responses, and; 3) Relative (%) changes. In addition, a threshold selection algorithm was 
applied to each data array (e.g., ICA shear, ICA diameter,), which identified threshold points for 
the increase in each variable following the onset of CO2 administration. Once the software had 
automatically detected the threshold points, they were depicted on the filtered and raw data array 
and visually inspected to ensure they met the following criteria:  a) the algorithm-detected 
threshold point occurred prior to the peak value and, b) the variable did not decrease below the 
algorithm-detected threshold point prior to the peak value occurring. Of the 240 responses 
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analyzed, 151 met the agreed criteria and their automatically detected points were accepted. In the 
remaining 89 cases (37%) the threshold points were manually adjusted by two independent 
investigators to a point where each deemed there was a clear deviation from baseline that met the 
above criteria. The mean of these manually assessed points were entered in the analysis.  The 
coefficient of variation for the analysis of the threshold points detected using the above systematic 
approach was 4.2% overall, and 11.2% between the 89 manually adjusted files. Shear rate area 
under the curve (AUC) was also calculated for both the transient and steady state trials, in 
accordance with the analytical methods used for brachial FMD(9, 40) (i.e., from the onset of CO2 
stimulus until peak dilation occurred). 
 
Data Exclusion Criteria 
Of the subjects tested, four trials were excluded from analysis of the steady state CO2 tests while 
seven were excluded from the transient CO2 tests. Additionally, there were three subjects who only 
completed the transient CO2 test (not both trials). Thus, the resulting samples sizes were n=20 for 
both the steady state CO2 and transient CO2 tests, with 13 subjects having repeated measures across 
both trials. Ultrasound videos were visually inspected prior to analyses and were excluded based 
upon the following criteria: 1) the occurrence of an overt angle change (n=2); 2) excessive 
movement of the vessel [e.g., due to high ventilation (n=3)]; and 3) overall poor image quality 
[e.g., blurry vessel walls (n=4)]. In two cases a test was excluded following video analysis due to 
low fidelity wall tracking despite the visual appearance of a clear vessel wall. Therefore, sample 
size is noted throughout the text for all statistical comparisons. 
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Statistical Analyses 
No statistical differences were found between male and female vascular responses in the current 
study; therefore, data were pooled for analyses. Sample sizes were based off of previous research 
by our group investigating vasomotion of the ICA (11, 21, 47). Comparisons between baseline and 
peak values within trial were made using two-tailed paired t-tests. Due to the differing participants 
for each trial (see Data Exclusion Criteria), between trial comparisons were made using a linear 
mixed model analysis with a compound symmetry covariance structure (Fixed factor: steady state 
vs. transient test) to account for this drop out. Pearson correlations were used to assess the 
relationship between vasodilatory responses during the transient and steady state CO2 protocols in 
the subjects with repeated measures (n=13), and to determine the relationship between shear AUC 
and dilation in each trial (transient n=19; steady state n=20). For the shear AUC and dilation 
bivariate analysis, a statistical outlier was determined utilizing bagplot analysis(34). All statistical 
analyses were performed using SPSS (IBM statistics, Version 22.0). 
 
 
RESULTS 
Carotid Shear-Mediated Dilation 
From the onset of elevated PETCO2 (Figure 3), the delay for ICA shear to increase was 16.8±13.2s 
in the transient trial and 18.2±14.2s (P=0.61) in the steady state trial. Peak shear occurred at 
42.2±9.9s in the transient trial and 163.6±87.5s in the steady state trial (P<0.01). The onset of 
dilation in the transient trial occurred 59.4±60.3s from onset of elevated PETCO2, while the delay 
was 110.3±79.6s in the steady state trial (P=0.047). Peak dilation occurred 110.3±69.1s and 
283.6±56.1s in the transient and steady state trial, respectively (P<0.01). In both the steady state 
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(18.2±14.2 vs. 110.3±79.6s; P<0.01) and transient test (16.8±13.2 vs. 59.4±60.3s; P<0.01) the 
increase in ICA shear preceded ICA dilation (Figure 3).  
 
During the transient and steady state hypercapnic tests the ICA dilated by 3.3±1.9% (n=20; 
P<0.01) and 5.3±2.9% (n=20; P<0.01), respectively. The steady state elevation in PETCO2 
produced the greatest dilation as reflected in a 60% greater increase (P=0.03; Figure 4). Shear rate 
increased from 330.0±74.2s-1 to a peak value of 448.5±111.7s-1 (n=20; P<0.01) in the transient 
CO2 trial and from 337.3±56.6s
-1 to 526.8±83.5s-1 (n=20; P<0.01) in the steady state trial. The 
increase in shear rate during the steady state trial was greater than during the transient test 
(189.5±49.9s-1 vs. 118.5±53.8s-1; P<0.01). Shear rate AUC for the transient trial was 
43,053±21,277s-1 (n=19), and 131,476±30,880s-1 (n=20) in the steady state trial (p<0.01; 
independent samples t-test). Shear rate AUC was correlated to the magnitude of vasodilation in 
the transient test (r2=0.44; P<0.01; n=19); however, this relationship was not present in the steady 
state trial (r2=0.02; P=0.53) (Figure 5). 
 
Intra- vs. Extra-Cranial Cerebral Hemodynamics 
Elevations in MCAv occurred at the same time as ICAv following the onset of hypercapnia in the 
transient (13.0±10.0 vs. 16.7±14.5; P=0.18) and steady state trials (15.1±14.9 vs. 16.9±13.9s; 
P=0.11), respectively (Figure 3). Peak MCAv and ICAv occurred at the same time in the transient 
(40.1±7.5 vs. 42.8±9.3s; P=0.09) and steady state (182.1±99.0 vs. 199.6±91.3s; P=0.24) trials. In 
the transient and steady state tests, peak ICA flow occurred 41.7±9.5s and 234.2±84.3s following 
the onset of CO2 breathing, respectively. 
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Blood Pressure Regulation 
During the transient CO2 test, MAP increased from 94.6±12.5mmHg to peak value of 
104.2±13.6mmHg (P<0.01), while the time of occurrence for peak MAP (81.2±73.1s) was not 
statistically different from the time of peak dilation (110.1±69.1s; P=0.20). However, the time to 
peak MAP and dilation were not related within subject (r2=0.14; P=0.06), nor was the magnitude 
of dilation and change in MAP (r2=0.09; P=0.22). During the steady state hypercapnia, MAP 
increased from 94.2±10.4mmHg to a peak value of 105.8±11.3mmHg (P<0.01), while the time of 
occurrence for peak MAP (169.0±96.3s) was earlier than that for peak dilation (283.6±56.1s; 
P<0.01). There was no relationship in the time to peak dilation and peak MAP (R2=0.002; P=0.43).  
 
 
DISCUSSION 
The present study outlines a novel experimental design aimed at: 1) assessing shear-mediated 
dilation of cerebral conduit arteries without the confounding influence of sustained increases in 
PaCO2, and 2) reinforcing the existence of shear mediated dilation of the ICA(10, 21). We 
observed dilation of the ICA in response to both transient and steady state hypercapnia. Under 
both conditions, increases in shear stress preceded dilation of the ICA in a time-dependent manner. 
Vasodilation of the ICA in the transient trial was strongly correlated to the increase in shear AUC, 
implicating shear as the primary stimulus for dilation, consistent with observations in the brachial, 
femoral, and coronary arteries(32). 
 
The assessment of FMD in peripheral arteries dates back >20 years to the landmark study by 
Celermajer et al., 1992(12). This technique evolved into a method for assessing the function and 
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health of endothelial cells in the general circulation(17). However, to date, there is no equivalent 
method of assessing cerebral conduit artery shear-mediated regulation. In humans, the ICA 
conveys blood flow to the brain and bilaterally this accounts for ~70% of global CBF(50). In 
addition to serving as cerebral conduit vessels, the ICAs regulate CBF(48) and provide the most 
accessible avenue(41) to assess cerebral endothelial function using duplex ultrasound. Therefore, 
the measurement of ICA diameter during a controlled and transient elevation in shear stress may 
provide a valid paradigm and for the specific assessment of cerebral conduit artery endothelial 
function (or dysfunction)(40). Whilst ischemia-induced hyperemia is utilized in peripheral FMD 
tests, this is obviously not possible in the cerebral vasculature(37). However, the present study 
indicates that hypercapnia-induced vasodilation, in particular utilizing transient exposure, induces 
ICA dilation following increases in intra-vascular shear stress of a similar manner and profile to 
post-occlusion cuff release(10). Given the congruent shear dynamics of a peripheral FMD test and 
the current carotid FMD test, in addition to the strong relationship between shear AUC and 
vasodilation, it appears that transient elevations in CO2 provide a robust (and relatively specific) 
method to perturb shear-mediated regulation of CBF. We therefore propose a novel technique to 
assess “cerebrovascular FMD” in the present study; however, pharmacological inhibition of 
endothelial NO synthase is necessary to confirm the potential applicability of this technique. The 
lack of correlation between shear AUC and dilation in the steady state trial indicates that sustained 
hypercapnia is likely not an adequate method to assess shear-mediated regulation of the ICA due 
to a larger influence of confounding factors (increased blood pressure etc.,). 
 
Our data implicate shear dependent mechanisms as key contributors to vasodilation in the ICA 
during a CO2 reactivity test (Figures 4 & 5) in accordance with previous study (10). Considering 
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the transient CO2 test elicited a more rapid, albeit lower, ICA dilation compared to the steady state 
test, our findings suggest that ICA dilation in the transient test is less influenced by extraneous 
factors (e.g., BP, sympathetic nervous activity, metabolism, direct effects of CO2/pH etc.,) As 
depicted in figure 5, the relationship between shear AUC and dilation occurs within a range 
between 0-100,000s-1, but in the steady state trial where shear AUC is >100,000s-1 this relationship 
is lost. This may be due to two potential factors: 1) a ceiling effect of shear on ICA vasodilation, 
and 2) that as previously mentioned, sustained CO2 engages other confounding physiological 
responses (e.g., elevated BP) that obscures the relationship between Shear AUC and vasodilation. 
Therefore, it appears the transient trial more closely resembles the NO-mediated FMD observed 
in the peripheral vasculature(17, 40), which is further supported by observations that other 
endothelial derived relaxing factors [e.g. prostaglandins(21)] do not possess an obligatory role in 
hypercapnic cerebral vasodilation. That the percent dilation was only modestly correlated within 
subjects between the transient and steady state CO2 tests indicates that distinct mechanisms may 
be evoked differentially in response to varying stimuli (i.e. time of hypercapnia).  This is consistent 
with findings from the peripheral FMD test, where five minutes of ischemia induces a largely NO-
mediated dilation, whereas longer periods of ischemia induce compensatory redundant 
mechanisms resulting in less NO dependency(24). However, it must be stressed that studies 
pharmacologically inhibiting endothelial nitric oxide synthase activity have not consistently 
demonstrated a role for NO in hypercapnic vasodilation(22, 35, 45). These variable findings may 
be related to the use of velocity indices of cerebral blood flow (CBF) [i.e. TCD; discussed in(2)], 
which are unable to detect and quantify changes in vessel diameter. In addition, systemic 
administration of NO blockers such as L-NMMA have both direct, and indirect reflex, effects on 
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vasomotor tone and these are countervailing, making the impacts of such drugs difficult to 
interpret.   
 
A delayed response (~60sec) to reach maximal steady state CBF for a given step change in PETCO2 
has been demonstrated previously(10, 36). Further, steady state hypercapnia is reported to elicit 
higher cerebrovascular reactivity than non-steady state tests [e.g., rebreathing(25)]. This disparity 
in reactivity may be explained by the time dependent nature of endothelial NO synthase 
upregulation and consequent NO mediated vasodilation, which may not be fully engaged at the 
termination of a progressive and dynamic stimulus. By quantifying the maximal dilation to a 
steady-state CO2 stimulus in addition to the vasomotor reaction to a transient elevation in CO2 and 
shear, we have provided insight into the percent contribution of shear-dependent mechanisms to 
total CO2 reactivity. Further, this highlights that ~40% of CO2 reactivity is not explained by shear, 
and may be partially attributable to changes in MAP(3, 26, 31), increases in cardiac output, and/or 
direct effects of PaCO2 /pH. The difference in time to peak dilation during the transient and steady-
state CO2 test likely indicates a different time course of these mechanism(s) on vasomotor tone. 
Therefore, while shear mechanisms likely acted in the same time course between tests, it is the 
additional stimuli that results in a further and delayed maximal dilation during steady state 
elevations in CO2.  
 
When considering the contribution of shear dependent mechanisms to cerebrovascular dilation one 
must also consider the potential for myogenic influences during hypercapnia-mediated increases 
in MAP(14). Increases in cerebral perfusion pressure have been shown to produce cerebral 
vasoconstriction(15); therefore, myogenic constriction may have masked vasodilation to some 
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degree (resulting in underestimation of shear-mediated vasodilation), and/or be related to the 
variable contribution of shear dependent mechanisms to hypercapnia mediated vasodilation. The 
opposing forces of shear-mediated dilation and myogenic constriction has been previously 
demonstrated in peripheral vessels(4, 29).  
 
Methodological considerations 
Recently it has become convention to normalize peripheral FMD tests via logarithmic 
transformation of baseline diameter, peak diameter, and shear rate AUC to allometrically scale for 
artery size and account for between subject variations in the shear stimulus (5, 6). The purpose of 
these corrections is to better estimate the endothelial responsiveness to a shear stimulus. Here, we 
have not scaled for baseline diameter and shear AUC between trials as the purpose of the current 
study was not to evoke and subsequently quantify a change in endothelial function, but to 
determine the experimental feasibility of a transient increase in ICA shear (via elevated PETCO2) 
in eliciting a measureable change in arterial diameter. Indeed endothelial function should not be 
different between the two trials given no intervention was present. 
 
While we have used dynamic end-tidal forcing to control PETCO2, determining the efficacy of the 
Douglas bag technique for a 30-second manipulation of CO2 may provide great utility, given the 
reduced technical demand and consequently easier transition into a clinical setting. Further 
determining the within and between-day variation in transient CO2 mediated ICA vasodilation will 
help determine its potential translation into a clinical setting. 
 
Perspective 
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Turbulent flow and non-uniform shear stress, which are characteristic of the carotid bulb and ICA, 
render the carotid vasculature a ‘high risk’ area for atherogenesis, wall thickening, and consequent 
vascular dysfunction(8, 16, 38). Therefore, the present carotid FMD test may possess future 
potential to detect early carotid and cerebral vascular dysfunction, before the development of overt 
wall thickening or intractable plaque deposition. Analogous to the peripheral FMD approaches, 
which predict future cardiovascular events(18), our carotid test may provide a useful clinical 
window into sub-clinical atherogenesis and also enable treat-to-target assessment of management 
efficacy. While steady state CO2 reactivity tests have shown a strong ability to predict cerebral 
vascular events in clinical populations [e.g., carotid stenosis(19)], they have yet to demonstrate 
predictive value relative to cerebral vascular risk in healthy individuals(30). The inability to 
specifically predict cerebral vascular risk may be related to several factors including: 1) previous 
use of velocity indices of CBF and consequent inability to directly quantify vasomotion(2, 13), 
and 2) the confounding nature of the myriad physiological consequences secondary to sustained 
hypercapnia [i.e., elevated blood pressure (33) and cardiac output (7), chemoreceptor mediated 
sympathoactivation (28), and the potential for direct vasodilatory effects of CO2/pH (21, 23, 47)]. 
Our approach mitigates these limitations by directly visualizing arterial diameter change and 
quantifying the magnitude and profile of the shear stimulus. It is tailored to perturb 
cerebrovascular endothelial function with reduced input from confounding physiological factors 
and couples concurrent measurement of cerebral conduit artery diameter, flow and shear at high 
temporal and spatial resolution. Future research should aim to 1) determine the influence of 
transiently elevated shear on ICA vasodilation prior to and following NO blockade to confirm 
endothelial involvement, and 2) determine the magnitude by which carotid shear-mediated dilation 
may be reflective of cerebral vascular health and risk of cerebrovascular events.  
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FIGURE LEGENDS 
 
Figure 1. Representative traces for the transient and steady state CO2 tests. Panel A depicts 
a typical response for the transient CO2 test and panel B depicts a typical response for the steady 
state CO2 test. Each panel displays PETCO2, PETO2, MCAv, ICA shear rate, and ICA diameter, 
with the raw data represented by the open grey circles, and the smoothed data represented by the 
closed black circles. The circled X’s indicate the response start and subsequent peak value of 
each hemodynamic variable, while the black bar denotes the duration of CO2 manipulation. 
 
Figure 2. Shear rate and diameter during the transient CO2 test. This figure highlights the 
temporal dynamics of the 30-second transient CO2 test in one subject. Time zero represents the 
onset of the 30-second CO2 stimulus (+9mmHg PETCO2). The increase in CO2 produced an 
increase in CBF and therefore cerebral shear rate (grey circles) which mirrors that subsequent to 
brachial cuff release during a peripheral FMD test [see figure 2 in(40)]. Shear rate area under the 
curve is highlighted in grey. Following the transient increase in shear rate, ICA diameter (open 
squares) increased approximately 30 seconds after peak shear rate was reached (51-seconds from 
CO2 onset). Peak diameter was reached approximately 60-seconds after peak shear occurred (80-
seconds from CO2 onset). 
 
Figure 3. The time course of cerebral vascular responses to steady state and transient CO2 
breathing. The presented data represents the threshold at which middle cerebral artery blood 
velocity (MCAv), internal carotid artery (ICA) shear, and ICA diameter begin to deviate (increase) 
from baseline. * Denotes a significant difference between steady state CO2 and transient CO2 
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response times. † Denotes a significant difference in the time delay between ICA shear and ICA 
dilation within a trial. 
 
Figure 4. Peak internal carotid artery dilation during the steady state and transient CO2 
tests. The left panel shows the change in diameter of the internal carotid artery (ICA) from 
baseline to peak dilation after a transient 30-second period of hypercapnia (+9mmHg) for 20 
subjects. The right panel shows the change in diameter of the ICA from baseline to peak dilation 
during four minutes of steady state hypercapnia (+9mmHg) for 20 subjects. The %change in 
diameter in the steady state trial was greater than the %change in diameter in the transient 30-
second trial (comparison of deltas between trials, P=0.03). Mean±SD is indicated for each trial 
by the filled circles (●) and error bars.  
 
Figure 5. The relationship between shear AUC and ICA dilation in the transient and steady 
state CO2 trials. The present data represent the stimulus-response relationship between shear area 
under the curve (AUC) and ICA vasodilation. In the transient trial, following removal of 
the statistical outlier (circled), shear area AUC was positively correlated with ICA vasodilation 
(r2=0.44; P<0.01). No relationship was present between shear AUC and ICA vasodilation in the 
steady state trial (r2=0.02;P=0.53). 
 
 
 
